Susan Harden

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

Corinne Faivre‐Finn, M. Snee, Linda Ashcroft et al. · The Lancet Oncology · 2017 · 548 citations · Full text

Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer

Davina Gale, Katrin Heider, Andrea Ruiz-Valdepeñas et al. · Annals of Oncology · 2022 · 319 citations · Full text

Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer.

Henning Usadel, Jan Brabender, K. D. Danenberg et al. · PubMed · 2002 · 303 citations

Lung Cancer Tissue, Epigenetic Change, Dna Methylation +18

British Thoracic Society Guideline for pleural disease

Mark Roberts, Najib M. Rahman, Nick Maskell et al. · Thorax · 2023 · 252 citations · Full text

Good Practice Points, Critical Care Medicine, Interventional Pulmonology +12

Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.

Susan Harden, Yutaka Tokumaru, William H. Westra et al. · PubMed · 2003 · 164 citations

Epigenetic Change, Dna Methylation, Pathology +22